Latest Insider Transactions at Acadia Pharmaceuticals Inc (ACAD)
This section provides a real-time view of insider transactions for Acadia Pharmaceuticals Inc (ACAD). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ACADIA PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ACADIA PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2018
|
Baker Bros. Advisors LP |
BUY
Other acquisition or disposition
|
Direct |
143,294
+50.0%
|
-
|
|
Nov 30
2018
|
Baker Bros. Advisors LP |
SELL
Other acquisition or disposition
|
Indirect |
489,977
-100.0%
|
-
|
|
Nov 30
2018
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
11,764,705
+18.63%
|
$199,999,985
$17.0 P/Share
|
|
Sep 20
2018
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
1,210,776
+1.34%
|
$21,793,968
$18.91 P/Share
|
|
Nov 27
2017
|
Baker Bros. Advisors LP |
SELL
Payment of exercise price or tax liability
|
Indirect |
1,941
-0.39%
|
$54,348
$28.0 P/Share
|
|
Nov 27
2017
|
Baker Bros. Advisors LP |
BUY
Exercise of conversion of derivative security
|
Indirect |
39,378
+7.41%
|
$39,378
$1.38 P/Share
|
|
Oct 13
2017
|
Baker Bros. Advisors LP |
SELL
Payment of exercise price or tax liability
|
Indirect |
55,457
-0.23%
|
$1,940,995
$35.4 P/Share
|
|
Oct 13
2017
|
Baker Bros. Advisors LP |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,426,590
+5.66%
|
$1,426,590
$1.38 P/Share
|